To study the effect of GPR30 and its specific agonist G1 on cardiac hypertrophy and myocardial fibrosis in the OVX + TAC mice, G1 was injected intraperitoneally every two days with a dose of 35 μg/kg. Here, GPER1 is linked to Myocardial fibrosis.